The Dry Powder Inhaler Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.globalinforesearch.com/reports/696083/dry-powder-inhaler-device
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Dry Powder Inhaler Device market size is estimated to be worth US$ 809.4 million in 2021 and is forecast to a readjusted size of USD 1115.5 million by 2028 with a CAGR of 4.7% during review period. Asthma accounting for % of the Dry Powder Inhaler Device global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Single Dose segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Dry Powder Inhaler Device include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, and Cipla, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Dry Powder Inhaler Device market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Single Dose
Multi Dose
Market segment by Application can be divided into
Asthma
COPD
Others
The key market players for global Dry Powder Inhaler Device market are listed below:
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dry Powder Inhaler Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dry Powder Inhaler Device, with price, sales, revenue and global market share of Dry Powder Inhaler Device from 2019 to 2022.
Chapter 3, the Dry Powder Inhaler Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dry Powder Inhaler Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, end user, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Dry Powder Inhaler Device market forecast, by regions, type and end user, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dry Powder Inhaler Device.
Chapter 13, 14, and 15, to describe Dry Powder Inhaler Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.
About Us:
GlobaI Info Research（GIR） is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
Table of Contents
1 Market Overview
1.1 Dry Powder Inhaler Device Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dry Powder Inhaler Device Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Single Dose
1.2.3 Multi Dose
1.3 Market Analysis by Application
1.3.1 Overview: Global Dry Powder Inhaler Device Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Asthma
1.3.3 COPD
1.3.4 Others
1.4 Global Dry Powder Inhaler Device Market Size & Forecast
1.4.1 Global Dry Powder Inhaler Device Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Dry Powder Inhaler Device Sales in Volume (2017-2028)
1.4.3 Global Dry Powder Inhaler Device Price (2017-2028)
1.5 Global Dry Powder Inhaler Device Production Capacity Analysis
1.5.1 Global Dry Powder Inhaler Device Total Production Capacity (2017-2028)
1.5.2 Global Dry Powder Inhaler Device Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Dry Powder Inhaler Device Market Drivers
1.6.2 Dry Powder Inhaler Device Market Restraints
1.6.3 Dry Powder Inhaler Device Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Dry Powder Inhaler Device Product and Services
2.1.4 GlaxoSmithKline Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Dry Powder Inhaler Device Product and Services
2.2.4 AstraZeneca Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Product and Services
2.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Chiesi
2.4.1 Chiesi Details
2.4.2 Chiesi Major Business
2.4.3 Chiesi Dry Powder Inhaler Device Product and Services
2.4.4 Chiesi Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Cipla
2.5.1 Cipla Details
2.5.2 Cipla Major Business
2.5.3 Cipla Dry Powder Inhaler Device Product and Services
2.5.4 Cipla Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 3M
2.6.1 3M Details
2.6.2 3M Major Business
2.6.3 3M Dry Powder Inhaler Device Product and Services
2.6.4 3M Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Hovione
2.7.1 Hovione Details
2.7.2 Hovione Major Business
2.7.3 Hovione Dry Powder Inhaler Device Product and Services
2.7.4 Hovione Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Mannkind
2.8.1 Mannkind Details
2.8.2 Mannkind Major Business
2.8.3 Mannkind Dry Powder Inhaler Device Product and Services
2.8.4 Mannkind Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business
2.9.3 Mylan Dry Powder Inhaler Device Product and Services
2.9.4 Mylan Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Novartis
2.10.1 Novartis Details
2.10.2 Novartis Major Business
2.10.3 Novartis Dry Powder Inhaler Device Product and Services
2.10.4 Novartis Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Schering/Merck
2.11.1 Schering/Merck Details
2.11.2 Schering/Merck Major Business
2.11.3 Schering/Merck Dry Powder Inhaler Device Product and Services
2.11.4 Schering/Merck Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Teva
2.12.1 Teva Details
2.12.2 Teva Major Business
2.12.3 Teva Dry Powder Inhaler Device Product and Services
2.12.4 Teva Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Vectura
2.13.1 Vectura Details
2.13.2 Vectura Major Business
2.13.3 Vectura Dry Powder Inhaler Device Product and Services
2.13.4 Vectura Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Dry Powder Inhaler Device Breakdown Data by Manufacturer
3.1 Global Dry Powder Inhaler Device Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Dry Powder Inhaler Device Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Dry Powder Inhaler Device
3.4 Market Concentration Rate
3.4.1 Top 3 Dry Powder Inhaler Device Manufacturer Market Share in 2021
3.4.2 Top 6 Dry Powder Inhaler Device Manufacturer Market Share in 2021
3.5 Global Dry Powder Inhaler Device Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Dry Powder Inhaler Device Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Dry Powder Inhaler Device Market Size by Region
4.1.1 Global Dry Powder Inhaler Device Sales in Volume by Region (2017-2028)
4.1.2 Global Dry Powder Inhaler Device Revenue by Region (2017-2028)
4.2 North America Dry Powder Inhaler Device Revenue (2017-2028)
4.3 Europe Dry Powder Inhaler Device Revenue (2017-2028)
4.4 Asia-Pacific Dry Powder Inhaler Device Revenue (2017-2028)
4.5 South America Dry Powder Inhaler Device Revenue (2017-2028)
4.6 Middle East and Africa Dry Powder Inhaler Device Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Dry Powder Inhaler Device Sales in Volume by Type (2017-2028)
5.2 Global Dry Powder Inhaler Device Revenue by Type (2017-2028)
5.3 Global Dry Powder Inhaler Device Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Dry Powder Inhaler Device Sales in Volume by Application (2017-2028)
6.2 Global Dry Powder Inhaler Device Revenue by Application (2017-2028)
6.3 Global Dry Powder Inhaler Device Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Dry Powder Inhaler Device Sales by Type (2017-2028)
7.2 North America Dry Powder Inhaler Device Sales by Application (2017-2028)
7.3 North America Dry Powder Inhaler Device Market Size by Country
7.3.1 North America Dry Powder Inhaler Device Sales in Volume by Country (2017-2028)
7.3.2 North America Dry Powder Inhaler Device Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Dry Powder Inhaler Device Sales by Type (2017-2028)
8.2 Europe Dry Powder Inhaler Device Sales by Application (2017-2028)
8.3 Europe Dry Powder Inhaler Device Market Size by Country
8.3.1 Europe Dry Powder Inhaler Device Sales in Volume by Country (2017-2028)
8.3.2 Europe Dry Powder Inhaler Device Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Dry Powder Inhaler Device Sales by Type (2017-2028)
9.2 Asia-Pacific Dry Powder Inhaler Device Sales by Application (2017-2028)
9.3 Asia-Pacific Dry Powder Inhaler Device Market Size by Region
9.3.1 Asia-Pacific Dry Powder Inhaler Device Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Dry Powder Inhaler Device Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Dry Powder Inhaler Device Sales by Type (2017-2028)
10.2 South America Dry Powder Inhaler Device Sales by Application (2017-2028)
10.3 South America Dry Powder Inhaler Device Market Size by Country
10.3.1 South America Dry Powder Inhaler Device Sales in Volume by Country (2017-2028)
10.3.2 South America Dry Powder Inhaler Device Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Dry Powder Inhaler Device Sales by Type (2017-2028)
11.2 Middle East & Africa Dry Powder Inhaler Device Sales by Application (2017-2028)
11.3 Middle East & Africa Dry Powder Inhaler Device Market Size by Country
11.3.1 Middle East & Africa Dry Powder Inhaler Device Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Dry Powder Inhaler Device Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Dry Powder Inhaler Device and Key Manufacturers
12.2 Manufacturing Costs Percentage of Dry Powder Inhaler Device
12.3 Dry Powder Inhaler Device Production Process
12.4 Dry Powder Inhaler Device Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Dry Powder Inhaler Device Typical Distributors
13.3 Dry Powder Inhaler Device Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Contact US
Global Info Research
E-mail: report@globalinforesearch.com
Tel: +86-13660489451 00852-58197708(HK)
WeChat: 17665052062
Add:FLAT/RM A 9/F SILVERCORP INTERNATIONAL TOWER 707-713 NATHAN ROAD MONGKOK KL HONG KONG
Website: http://www.globalinforesearch.com
No comments:
Post a Comment